Healthcare/Biotech
USFDA pulls up Granules India for lapses in maintaining storage facilities, equipment at Telangana plant
The USFDA has issued a warning to Granules India for contamination and improper equipment maintenance at its Telangana facility. Inspectors found significant contamination, bird droppings, and torn CGMP records during their visit. The agency demands prompt corrective actions from the company to rectify these violations, emphasizing the need for effective oversight and improved quality systems.
- Protecting your heart and managing diabetes: The power of a holistic lifestyle
- Indian Pharmaceutical Alliance calls for zero import duty on US drugs to boost local industry
- Registration for Ayushman Bharat to start after March 8: Delhi health minister
- Surge in fake medicines in retail markets leaving druggists distraught: Traders' body
- Apollo Health picks up controlling stake in Lucknow-based Care Diagnostics
- AstraZeneca gets nod to import, sell hyperkalaemia treatment drug in India
- Lasik surgery in 10 seconds? This AI-powered tech may challenge the traditional course of treatment for eye care
- Clinical research entities asked to register by April 1
- Zydus Lifesciences launches breakthrough drug for transplant patients
- Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccine
- India set to introduce list of OTC drugs this month
- Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories
Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccine
India set to introduce list of OTC drugs this month
Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories
Zydus to develop combination vaccine for shigellosis and typhoid
Diabetes and obesity: The duo you need to break up with
AstraZeneca Pharma India gets CDSCO approval to import, sell cancer treatment medicine
Biotech
States to set up centres for effective implementation of BioE3 policy: Jitendra Singh- Competition Commission of India penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal
- India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched
- US co Intuitive Surgical bets on India growth & talent: CEO Gary S Guthart
- The Hitchhiker’s Guide to Immortality: Tech entrepreneur Bryan Johnson on 'don’t die' philosophy and mortality
Healthcare
Protecting your heart and managing diabetes: The power of a holistic lifestyle- Registration for Ayushman Bharat to start after March 8: Delhi health minister
- Apollo Health picks up controlling stake in Lucknow-based Care Diagnostics
- Lasik surgery in 10 seconds? This AI-powered tech may challenge the traditional course of treatment for eye care
- Diabetes and obesity: The duo you need to break up with
Pharmaceuticals
Surge in fake medicines in retail markets leaving druggists distraught: Traders' body
AstraZeneca gets nod to import, sell hyperkalaemia treatment drug in India
Zydus Lifesciences launches breakthrough drug for transplant patients
Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccine
Must Watch
BACK TO TOP